News & Blog

Tag Archives: pharmaceutical companies

Your Experience. Your Voice. Your Treatment.

Earlier this year, we shared a number of blogs about our Clinical Trial Endpoints Initiative. National Brain Tumor Society is working with the FDA, the National Cancer Institute, medical academic researchers, clinicians, and the Jumpstarting Brain Tumor Drug Development Coalition (a group of other brain tumor-focused nonprofits and organizations), with the goal of developing action […]

Recently in Brain Tumor Research: Reporting back from the 2014 American Society of Clinical Oncology Annual Meeting

With more than 30,000 attendees from across the oncology field, the American Society of Clinical Oncology’s (ASCO) Annual Meeting is one of the largest and most important yearly gatherings in the field of cancer research.  This year’s 50th ASCO annual meeting (May 30 – June 3) was one of the biggest to-date, with the society […]

Can Army Cadets from West Point Help Pediatric Brain Tumor Treatments Get to Market?

During a mid-March scientific and policy meeting, a group of cadets from the United States Military Academy at West Point – none biology or pre-med majors – stood before a group of leading international pediatric cancer researchers, representatives from major biopharmaceutical companies, and officials from government agencies like the National Cancer Institute, U.S. Food and […]

Share